Price $8.24 |
Market Cap
293.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
-
|
P/B
8.57
|
P/S
2.34
|
Dividend %
-
|
|
P/CF
73.5
|
P/FCF
-
|
Op. Cash Flow
-18.7K
|
FCF
-1.1
|
|
Op. Margin
-22.40%
|
Net Margin
-60.10%
|
ROE
-107.90%
|
ROI
-22.70%
|
|
ROA
-28.40%
|
EPS Growth
-0.30%
|
Current Ratio
0.7
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Soligenix Inc (SNGX) | $0.53 | - | - | 5.7M | Strong Buy |
| Paratek Pharmaceuticals Inc (PRTK) | $2.19 | - | - | 126.6M | Strong Buy |
| Immunome Inc (IMNM) | $7.26 | - | - | 96.6M | Strong Buy |
| Chromadex Corp (CDXC) | $1.42 | - | - | 117.7M | Strong Buy |
| InMed Pharmaceuticals Inc (INM) | $0.82 | - | - | 3.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
